Gabriel van der Pluijm
- Naam
- G. van der Pluijm
- Telefoon
- 31651743066
- g.van_der_pluijm@lumc.nl
- LUMC-extern
Contact
- Chen L., Groenewoud A., Tulotta C., Zoni E., Kruithof-de Julio M., Horst G. van der, Pluijm G. van der & Snaar-Jagalska B.E. (2017), A Zebrafish Xenograft Model for Studying Human Cancer Stem Cells in distant metastasis and therapy response, Methods in Cell Biology 138: 471-494.
- Zoni E., Chen L., Karkampouna S., Granchi Z., Verhoef E.I., La Manna F., Kelber J., Pelger R.C.M., Henry M.D., Snaar-Jagalska B.E., Leenders G.J.L.H. van, Beimers L., Kloen P., Gray P.C., Pluijm G. van der & Kruithof-de Julio M. (2017), CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer, Oncogene 36: 4739-4749.
- Chen L., Groenewoud A., Pluijm G. van der & Snaar-Jagalska B.E. (2016), A zebrafish xenograft model for studying human cancer stem cells in distant metastasis and therapy response, Methods in Cell Biology 138: 471–496.
- Naber H.P.H., Wiercinska E., Pardali E., Laar T. van, Nirmala E., Sundqvist A., Dam H. van, Horst G. van der, Pluijm G. van der, Heckmann B., Danen E.H.J. & Dijke P. ten (2012), BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression, Cellular Oncology 35(1): 19-28.
- Rentsch C.A., Cecchini M.G., Schwaninger R., Germann M., Markwalder R., Heller M., Pluijm G. van der, Thalmann G.N. & Wetterwald A. (2006), Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer, INTERNATIONAL JOURNAL OF CANCER : .